ARCHIVES

Funding Opportunities.

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

President Accepts Rauscher Resignation

October 1, 1976

Book Offers Info For Women Considering Ovary Removal

November 24, 2006

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer

June 5, 2009

NIH Deputy Director Ruth Kirschstein Plans Transition To Senior Advisor

October 4, 2002

Guideline Revisions or Outstanding Investigator Grant Still Controversial

December 9, 1983